Results 1 to 10 of about 590,699 (329)

QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative Analysis. [PDF]

Aging Dis, 2023
Parkinson’s disease (PD) and atypical parkinsonism (AP), including progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), share similar nonmotor symptoms.
Liu H, Huang Z, Deng B, Chang Z, Yang X, Guo X, Yuan F, Yang Q, Wang L, Zou H, Li M, Zhu Z, Jin K, Wang Q.   +13 more
europepmc   +4 more sources

Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson’s disease and atypical parkinsonism [PDF]

npj Parkinson's Disease, 2023
Objective measures of disease progression are critically needed in research on Parkinson’s disease (PD) and atypical Parkinsonism but may be hindered by both practicality and cost.
Bradley J. Wilkes, Emily R. Tobin, David J. Arpin, Wei-en Wang, Michael S. Okun, Michael S. Jaffee, Nikolaus R. McFarland, Daniel M. Corcos, David E. Vaillancourt   +8 more
doaj   +3 more sources

Luxembourg Parkinson's study -comprehensive baseline analysis of Parkinson's disease and atypical parkinsonism. [PDF]

Front Neurol, 2023
Background Deep phenotyping of Parkinson’s disease (PD) is essential to investigate this fastest-growing neurodegenerative disorder. Since 2015, over 800 individuals with PD and atypical parkinsonism along with more than 800 control subjects have been ...
Pavelka L, Rawal R, Ghosh S, Pauly C, Pauly L, Hanff AM, Kolber PL, Jónsdóttir SR, Mcintyre D, Azaiz K, Thiry E, Vilasboas L, Soboleva E, Giraitis M, Tsurkalenko O, Sapienza S, Diederich N, Klucken J, Glaab E, Aguayo GA, Jubal ER, Perquin M, Vaillant M, May P, Gantenbein M, Satagopam VP, Krüger R, NCER-PD Consortium.   +27 more
europepmc   +4 more sources

Atypical Parkinsonism: Methamphetamine may play a role [PDF]

Clinical Case Reports, 2022
Abusing methamphetamine can be considered as an agent that can cause or affect the course of atypical parkinsonian syndromes (APS), which may raise attention regarding preventing abusing these drugs.
Mehri Salari, Fatemeh Hojjati Pour, Ronak Rashedi, Masoud Etemadifar   +3 more
doaj   +3 more sources

Assessment of APOE in atypical parkinsonism syndromes

Neurobiology of Disease, 2019
Atypical parkinsonism syndromes are a heterogeneous group of neurodegenerative disorders that include corticobasal degeneration (CBD), Lewy body dementia (LBD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP).
Marya S. Sabir, Cornelis Blauwendraat, Sarah Ahmed, Geidy E. Serrano, Thomas G. Beach, Matthew Perkins, Ann C. Rice, Eliezer Masliah, Christopher M. Morris, Lasse Pihlstrom, Alexander Pantelyat, Susan M. Resnick, Mark R. Cookson, Dena G. Hernandez, Marilyn Albert, Ted M. Dawson, Liana S. Rosenthal, Henry Houlden, Olga Pletnikova, Juan Troncoso, Sonja W. Scholz   +20 more
doaj   +3 more sources

Anti-Collapsin Response Mediator Protein 5(CV2/CRMP5) and Anti-Glutamic Acid Decarboxylase (GAD) Antibodies-Mediated Encephalopathy Mimicking Atypical Parkinsonism [PDF]

Neurology International
Background: Paraneoplastic neurological syndromes (PNSs) are rare conditions characterized by immune-mediated pathogenesis, frequently associated with the presence of a neoplasm.
Giuseppe Schirò, Matteo Gastaldi, Salvatore Iacono, Silvia Scaranzin, Valentina Picciolo, Valentina Arnao, Anita Ferrari, Cesare Gagliardo, Marco D’Amelio   +8 more
doaj   +4 more sources

Genotype–Phenotype Relations for the Atypical Parkinsonism Genes: MDSGene Systematic Review [PDF]

Movement Disorders, 2021
This Movement Disorder Society Genetic mutation database Systematic Review focuses on monogenic atypical parkinsonism with mutations in the ATP13A2, DCTN1, DNAJC6, FBXO7, SYNJ1, and VPS13C genes.
Christina Wittke, Sonja Petkovic, Valerija Dobričić, Susen Schaake, Gesine Respondek, Anne Weißbach, Harutyun Madoev, Joanne Trinh, Eva‐Juliane Vollstedt, Neele Kuhnke, Katja Lohmann, Marija Dulovic Mahlow, Connie Marras, Inke R. König, María Stamelou, Vincenzo Bonifati, Christina M. Lill, Meike Kasten, Hans‐Jürgen Huppertz, Günter U. Höglinger, Christine Klein, Christine Klein   +21 more
openalex   +2 more sources

Retinal Structure Abnormalities in Parkinson's Disease and Atypical Parkinsonism. [PDF]

Biomolecules, 2023
We investigated retinal structure changes in patients with Parkinson’s disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and controls, and explored the value of this method in differential diagnosis.
Ma X, Li S, Zheng B, Hu L, Liu H, Wang Z, Wang Z, Chen H, Su W.   +8 more
europepmc   +2 more sources

Diagnostic accuracy of cerebral [¹⁸F]FDG PET in atypical parkinsonism. [PDF]

EJNMMI Res, 2023
Background Atypical parkinsonism (AP) often presents with Parkinson’s symptoms but has a much worse long-term prognosis. The diagnosis is presently based on clinical criteria, but a cerebral positron emission tomography (PET) scan with [^18F]fluoro-2 ...
Houssein NJ, Henriksen AC, Hejl AM, Marner L.   +3 more
europepmc   +2 more sources

Differences in Striatal Metabolism in [¹⁸F]FDG PET in Parkinson's Disease and Atypical Parkinsonism. [PDF]

Diagnostics (Basel), 2022
Neurodegenerative parkinsonisms affect mainly cognitive and motor functions and are syndromes of overlapping symptoms and clinical manifestations such as tremor, rigidness, and bradykinesia.
Seiffert AP, Gómez-Grande A, Alonso-Gómez L, Méndez-Guerrero A, Villarejo-Galende A, Gómez EJ, Sánchez-González P.   +6 more
europepmc   +2 more sources